Table 3.

Results of multivariate Cox analysis for potential effect on TRM

VariableBaseline valueCompared valueRR (95% CI)P
Cell dose ≤ 2.4 × 108/kg > 2.4 × 108/kg and ≤ 5 × 108/kg 0.76 (0.58-0.99)  
  > 5 × 108/kg 0.6 (0.41-0.88) .002  
Donor type HLA-identical sibling Alternative 2.19 (1.61-2.97) .0001  
Year of transplantation 1987 or before 1997 or before 0.44 (0.33-0.6)  
  After 1997 0.32 (0.21-0.5) .0001  
Conditioning regimen TBI: yes TBI: no 1.36 (1.04-1.77) .02  
Recipient age ≤ 30 y > 30 y 1.02 (1.00-1.03) .02  
Donor age ≤ 31 y > 31 y 1.01 (1.00-1.02) .06  
Disease phase Early Advanced 1.25 (0.99-1.59) .06 
VariableBaseline valueCompared valueRR (95% CI)P
Cell dose ≤ 2.4 × 108/kg > 2.4 × 108/kg and ≤ 5 × 108/kg 0.76 (0.58-0.99)  
  > 5 × 108/kg 0.6 (0.41-0.88) .002  
Donor type HLA-identical sibling Alternative 2.19 (1.61-2.97) .0001  
Year of transplantation 1987 or before 1997 or before 0.44 (0.33-0.6)  
  After 1997 0.32 (0.21-0.5) .0001  
Conditioning regimen TBI: yes TBI: no 1.36 (1.04-1.77) .02  
Recipient age ≤ 30 y > 30 y 1.02 (1.00-1.03) .02  
Donor age ≤ 31 y > 31 y 1.01 (1.00-1.02) .06  
Disease phase Early Advanced 1.25 (0.99-1.59) .06 

TRM indicates transplant-related mortality; RR, relative risk; CI, confidence interval; and TBI, total body irradiation.

Close Modal

or Create an Account

Close Modal
Close Modal